Unraveling the secrets behind beta cells

Exploring this avenue may help to advance diabetes research

5:00 AM

Author | Miranda Trotman

Scott Soleimanpour, M.D., sits in front of a computer screen picturing beta cells
Scott Soleimanpour, M.D., associate director of the Elizabeth Weiser Caswell Diabetes Institute and co-director of the Pilot and Feasibility Program, working in the Soleimanpour lab. Credit: Camren Clouthier

Diabetes has a significant global impact, affecting 40 million individuals in the United States alone, with burdensome and sometimes devastating complications. 

Treating, curing and preventing diabetes requires innovative research in order to lead to groundbreaking therapies.

One approach to better understanding the disease’s mechanisms? Delving into the intricacies of beta cells, say experts of Michigan Medicine’s Caswell Diabetes Institute's Islet Program, a program established in 2020.

The Islet Program at the Caswell Diabetes Institute is at the forefront of this type of revolutionary research, aiming to spearhead the development of effective treatments. 

Scott Soleimanpour, M.D., associate director of the Elizabeth Weiser Caswell Diabetes Institute and director of the Michigan Diabetes Research Center, as well as a practicing endocrinologist and diabetes patient himself, is passionate about finding a cure and advancing therapies for the disease. 

"The whole point is to cure the disease." 

Soleimanpour leads a team dedicated to understanding the behavior and complexities of beta cells. They seek to unlock these secrets of diabetes at a molecular level, and ultimately develop personalized treatments to address the root causes of the condition.

Unraveling beta cell secrets

Within the pancreas live clusters of cells called islets, and it’s within these islets that beta cells are found. 

Beta cells are a small, but important, component within the pancreas, making up only 2% of the organ's overall volume. 

Despite their small numbers, these cells carry out a crucial function in the body – the production of insulin. Insulin is a hormone that regulates blood sugar by allowing cells to take in glucose from the bloodstream. 

U-M researchers believe the intricate workings of beta cells may hold the key to tackling the challenges posed by both Type 1 and Type 2 diabetes.

In Type 1 diabetes, beta cells don’t work well and the immune system mistakenly destroys beta cells, causing a lack of insulin. 

In Type 2 diabetes, beta cells are unable to make enough insulin to keep up with the body’s demand and eventually fail. 

Understanding beta cells is important for finding treatments for both of these common conditions, says Soleimanpour. 

By providing a support structure for various labs dedicated to beta cell research, the program aims to understand the behavior and complexities of these cells to ultimately find a solution for insulin deficiencies.

Stem cell therapies

And a way the Islet Program is spearheading that? 

By developing humanized beta cell systems, which include leveraging reprogrammed stem cells obtained from donors with and without diabetes, to develop realistic representations of human beta cells, as well as developing new technologies to study human islets from deceased donors with diabetes. 

These approaches benefits patients by applying research findings and advancing tailored treatments and individualized care. 

In this way, stem cell therapies may eventually emerge as a potential alternative to reduce dependence on insulin injections.

"Stem cell therapies, may or may not be the cure, or at least a contributor to one. But either way, we're working aggressively to figure that out in the next two to five years."

The program actively seeks collaborations with funding partners and welcomes investments to support its mission. 

The Caswell Diabetes Institute supports rigorous science and its integration with patient centered clinical care, leading the way to prevent, treat, and cure diabetes, its complications, and related metabolic diseases.


More Articles About: Diabetes Diabetes Education Diabetes Management Diabetes Support Metabolism, Endocrinology & Diabetes Type 1 Diabetes type 2 diabetes
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories finger pointing at person
Health Lab
Examining mental health and reducing stigma in diabetes
Research at Michigan Medicine has been working to improve the psychosocial concerns related to diabetes, which often pose issues for people living with the condition
eye flashlight in exam close up of woman's eye
Health Lab
Diabetic retinopathy is being diagnosed more in younger patients
Although previously rare in young people with diabetes, an editorial in JAMA Ophthalmology notes that diabetic retinopathy is increasing in younger patients, urging clinicians to remain vigilant of symptoms.
holding syringe white shirt close up in hands
Health Lab
Could GLP1RA drugs lower high iron levels?
GLP1RA drugs are used to treat obesity as well as type 2 diabetes. Research from University of Michigan Health finds that these drugs can also be effective in treating high iron levels, a cause and symptom of type 2 diabetes.
pill bottle spilling yellow blue
Health Lab
Drug used for alcoholism shows potential for stopping inflammatory disease
A study shows that disulfiram, known for causing severe hangover symptoms by blocking alcohol breakdown, also inhibits the inflammatory NLRP3 complex.
hands holding syringe white
Health Lab
How do GLP-1 weight loss drugs affect the liver?
Glucagon-like peptide-1, or GLP-1, receptor agonists, that aid in weight loss, are now being investigated for their ability to help other patients, including those with liver disease. However, a research letter discusses the first known case of hepatitis and jaundice in a patient taking these drugs.
person handling medicine
Health Lab
Older adults want to cut back on medication, but study shows need for caution
The idea of deprescribing is popular among older adults who take prescription drugs, especially those taking medication for symptomless conditions like high blood pressure.